Evidence map›Paper›PMID 40014690›Full record

ArticleScience (New York, N.Y.)2025

TIGR-Tas: A family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses.

Guilhem Faure, Makoto Saito, Max E Wilkinson, Natalia Quinones-Olvera, Peiyu Xu, Daniel Flam-Shepherd, Stephanie Kim, Nishith Reddy, Shiyou Zhu, Lilia Evgeniou and 3 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. 3D Genome Engineering Using CRISPR/dCas Systems.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Angiogenic Doping: Plausible Yet Difficult to Detect.Sports medicine (Auckland, N.Z.) · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Protein foundation models: a comprehensive survey.Science China. Life sciences · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Epigenome editing based treatment: Progresses and challenges.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Review
  16. Review
  17. Review
  18. Comprehensive Analysis of thePlants (Basel, Switzerland) · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Guilhem Faure *Howard Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0001-9537-2277
Makoto Saito *Howard Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0001-8619-5176
Max E Wilkinson *Howard Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0003-4738-9503
Natalia Quinones-OlveraHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0002-4612-6819
Peiyu XuHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0003-3590-4037
Daniel Flam-ShepherdHoward Hughes Medical Institute, Cambridge, MA, USA.
Stephanie KimHoward Hughes Medical Institute, Cambridge, MA, USA.
Nishith ReddyHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0001-5912-6925
Shiyou ZhuHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0009-0001-2677-8262
Lilia EvgeniouHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0009-0005-5707-2413
Eugene V KooninNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-3943-8299
Rhiannon K MacraeHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0002-7850-9056
Feng ZhangHoward Hughes Medical Institute, Cambridge, MA, USA.ORCID 0000-0003-0178-7995

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

RNA-guided systems provide remarkable versatility, enabling diverse biological functions. Through iterative structural and sequence homology-based mining starting with a guide RNA-interaction domain of Cas9, we identified a family of RNA-guided DNA-targeting proteins in phage and parasitic bacteria. Each system consists of a tandem interspaced guide RNA (TIGR) array and a TIGR-associated (Tas) protein containing a nucleolar protein (Nop) domain, sometimes fused to HNH (TasH)- or RuvC (TasR)-nuclease domains. We show that TIGR arrays are processed into 36-nucleotide RNAs (tigRNAs) that direct sequence-specific DNA binding through a tandem-spacer targeting mechanism. TasR can be reprogrammed for precise DNA cleavage, including in human cells. The structure of TasR reveals striking similarities to box C/D small nucleolar ribonucleoproteins and IS110 RNA-guided transposases, providing insights into the evolution of diverse RNA-guided systems.

Indexed as

Bacterial ProteinsBacteriophagesClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsEubacterialesGene EditingRNA, Guide, CRISPR-Cas SystemsDNAHumansProtein DomainsBacterial ProteinsDNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID40014690
PMCPMC12045711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.